KoreaTimes(779) - Bio, Business, page 3

Entertainment
& Arts

Sports

World

SCMP
Asia

Video

Photos

Site Map E-paper Subscribe Register LogIn
Site Map E-paper Subscribe Register LogIn

Business

Bio

Sun, August 14, 2022 | 12:53

Lotte seeks to acquire US CMO plant to enter bioindustry

Lotte Group is in the process of acquiring a bioindustry contract manufacturing (CMO) plant in the U.S., according to the investment banking industry, Thursday. The move comes after the conglomerate declared the bioindustry as its new growth engine. CMOs specialize in producing biopharmaceuticals developed by other companies.

Kim Hyun-bin | 2022-05-05 14:46

CHA Biotech's US subsidiary opens CDMO plant in Texas

Matica Biotechnology, a U.S. affiliate of CHA Biotech, has opened a cell and gene therapy manufacturing facility in College Station, Texas, according to the cell therapeutics and stem cell developer affiliate of CHA Medical & Bio Group, Wednesday.

Lee Kyung-min | 2022-05-04 15:53

Osstem Implant posts record profits for Q1

Osstem Implant posted a record operating profit for the first quarter, the dental equipment manufacturer said Friday.

Baek Byung-yeul | 2022-04-29 16:30

HLB posts earnings surprise in Q1

Local biotech company HLB posted sales and operating profit records for the first quarter. The company announced on April 25 that its quarterly sales rose a whopping 1,052 percent from the same period in 2021 to 63.4 billion won ($50.8 million). Its operating profit also came to 18.8 billion won to turn into a surplus. Both sales and operating profit figures were the highest ...

Baek Byung-yeul | 2022-04-26 15:12

Moon hails Phase 3 trial of SK Bioscience's COVID-19 vaccine

President Moon Jae-in praised a successful Phase 3 trial of the nation's first homegrown COVID-19 vaccine, developed by SK Bioscience, Tuesday.

2022-04-26 15:09

Yoon to visit headquarters of homegrown COVID-19 vaccine

President-elect Yoon Suk-yeol will visit homegrown vaccine producer SK Bioscience on Monday and emphasize vaccine sovereignty amid the country's fight against the novel coronavirus, his spokesperson said.

2022-04-25 10:58

SD Biosensor, Korean COVID-19 test kit maker, to buy Italian firm for 61.9 billion won

SD Biosensor, a Korean developer of COVID-19 test kits, said Friday it has signed a deal to buy an Italian medical device distributor for 61.9 billion won ($49.8 million) in an effort to tap deeper into the European market.

2022-04-22 15:10

SK bioscience to develop antiviral nasal spray

SK bioscience, a biotech affiliate of SK Group, said Wednesday that it will develop a spray-type antiviral drug, with research funds provided by the Bill & Melinda Gates Foundation, a private foundation.

Lee Kyung-min | 2022-04-14 09:03

Medytox takes patent fight with Hugel to USITC

Another patent war among domestic botulinum toxin (BTX or Botox) makers has broken out after Medytox accused its local competitor, Hugel, of stealing its BTX strains, filing a lawsuit with the United States International Trade Commission (USITC), according to company officials, Tuesday.

Baek Byung-yeul | 2022-04-05 16:47

Samsung Biologics eyes global market with acquisition of Samsung Bioepis: CEO

Samsung Biologics, the biotech arm of Korea's Samsung Group, aims to expand its presence in the global market through full ownership of Samsung Bioepis, its chief executive said Tuesday.

2022-03-29 15:35

1 2 3 4 5

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.